Login
Products
Login
Home
Alerts
Search
Watchlists
Products

Indraprastha Medical Corporation Ltd

INDRAMEDCO
NSE
429.50
3.37%
Last Updated:
08 Apr '26, 3:11 PM
Company Overview
Alert
Watchlist
Note

Indraprastha Medical Corporation Ltd

INDRAMEDCO
NSE
429.50
3.37%
08 Apr '26, 3:11 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,937Cr
Close
Close Price
429.50
Industry
Industry
Hospitals
PE
Price To Earnings
21.53
PS
Price To Sales
2.71
Revenue
Revenue
1,451Cr
Rev Gr TTM
Revenue Growth TTM
8.53%
PAT Gr TTM
PAT Growth TTM
21.03%

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
274307317306315348350325334365381372
Growth YoY
Revenue Growth YoY%
27.016.411.510.714.813.510.36.06.04.98.914.4
Expenses
ExpensesCr
241259267259266281286273272292310310
Operating Profit
Operating ProfitCr
334750474867645261737162
OPM
OPM%
12.115.415.915.415.419.318.216.118.420.018.716.7
Other Income
Other IncomeCr
544455656777
Interest Expense
Interest ExpenseCr
111122221221
Depreciation
DepreciationCr
101010101011111111101111
PBT
PBTCr
274044414260574555686656
Tax
TaxCr
71011111015151214171715
PAT
PATCr
203133293145423341514941
Growth YoY
PAT Growth YoY%
30.550.430.740.957.146.829.111.431.614.916.625.0
NPM
NPM%
7.29.910.49.69.912.912.110.112.314.113.011.0
EPS
EPS
2.23.33.63.23.44.94.63.64.55.65.44.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
7147557667537888316138881,0991,2451,3561,451
Growth
Revenue Growth%
5.45.71.4-1.74.75.4-26.244.823.713.39.07.0
Expenses
ExpensesCr
6306766876807077445737749481,0511,1121,184
Operating Profit
Operating ProfitCr
85797973818640114151193244268
OPM
OPM%
11.910.510.39.710.310.46.612.913.715.518.018.4
Other Income
Other IncomeCr
1201011310172328
Interest Expense
Interest ExpenseCr
878976334466
Depreciation
DepreciationCr
283531313033333539404443
PBT
PBTCr
503941344548479117166216246
Tax
TaxCr
1714151316522031425563
PAT
PATCr
32242621284425986124161183
Growth
PAT Growth%
-8.3-24.87.4-19.634.653.5-94.72,415.947.043.929.913.6
NPM
NPM%
4.53.23.42.83.65.30.46.67.810.011.912.6
EPS
EPS
3.52.72.92.33.14.80.36.49.413.517.619.9

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
929292929292929292929292
Reserves
ReservesCr
103132139141152176181234288386505567
Current Liabilities
Current LiabilitiesCr
19419118613812414011694130165179223
Non Current Liabilities
Non Current LiabilitiesCr
534642625442434346807673
Total Liabilities
Total LiabilitiesCr
442461458432422449432462555723852954
Current Assets
Current AssetsCr
149152158133136141141157223308431594
Non Current Assets
Non Current AssetsCr
293308301299287308291304332415420360
Total Assets
Total AssetsCr
442461458432422449432462555723852954

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
6462284875862794144200157
Investing Cash Flow
Investing Cash FlowCr
-29-33-22-30-17-40-19-74-108-158-111
Financing Cash Flow
Financing Cash FlowCr
-35-30-5-17-44-43-3-3-26-32-46
Net Cash Flow
Net Cash FlowCr
00011445171190
Free Cash Flow
Free Cash FlowCr
35295175846665100131120
CFO To PAT
CFO To PAT%
197.9254.8105.3226.0264.6198.21,150.6160.9167.7161.597.4
CFO To EBITDA
CFO To EBITDA%
75.878.435.165.593.1100.166.682.595.9103.564.2

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5104764864433523114935367131,5743,539
Price To Earnings
Price To Earnings
17.519.518.621.012.47.1215.09.28.312.722.0
Price To Sales
Price To Sales
0.70.60.60.60.50.40.80.60.71.32.6
Price To Book
Price To Book
2.62.12.11.91.41.21.81.61.93.35.9
EV To EBITDA
EV To EBITDA
6.36.56.96.84.33.411.64.13.97.213.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
OPM
OPM%
11.910.510.39.710.310.46.612.913.715.518.0
NPM
NPM%
4.53.23.42.83.65.30.46.67.810.011.9
ROCE
ROCE%
25.117.016.514.719.919.92.824.931.833.335.4
ROE
ROE%
16.710.911.49.111.616.30.818.022.725.927.0
ROA
ROA%
7.45.35.74.96.79.70.512.715.517.118.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Indraprastha Medical Corporation Ltd (IMCL), operating as **Indraprastha Apollo Hospitals**, is a leading integrated healthcare provider in India and a flagship entity within the **Apollo Hospitals Group**—India’s largest and first corporate healthcare chain, established in 1983. With a strong foundation in clinical excellence, technological innovation, and patient-centric care, IMCL continues to strengthen its market leadership through strategic expansion, digital transformation, and a focus on preventive and precision medicine. Designated a trusted destination for **Medical Value Travel (MVT)**, IMCL has treated patients from over 150 countries for more than four decades. Its reputation for high-quality outcomes, international safety standards, and affordable care positions it as a key player in India’s push toward becoming a global healthcare hub. --- ### **Integrated Healthcare Delivery Model: "One Apollo"** Apollo is unifying its vast network of: - Hospitals - Clinics - Diagnostics - Pharmacies - Digital platforms - Home care - Insurance services Under the **“One Apollo”** initiative, creating a seamless, **end-to-end care continuum** across all touchpoints. This integrated model enhances patient experience, operational efficiency, and care coordination. --- ### **Digital & Technological Innovation** IMCL is accelerating its digital transformation through advanced technology and strategic partnerships: - **"One Apollo" Tech Integration**: Collaboration with **Microsoft** enables cloud-based systems and intelligent automation to streamline clinical workflows and enhance data interoperability. - **Apollo 24|7 – Digital Health Powerhouse**: - Over **33 million registered users** (up from 25 million in 2023) - Offers **virtual consultations within 15 minutes**, including emergency care - Medicine delivery in **under 2 hours across 19,000+ pincodes** - Home sample collection, **digital EMR (health vault)**, diagnostics, and specialist treatments - Serves as a **360-degree digital health ecosystem** - **"Ask Apollo" Platform**: Streamlines appointment booking and online consultations for outpatient needs. --- ### **Centers of Excellence (COEs) & Clinical Leadership** IMCL operates **specialized COEs** in: - Cardiac Sciences - Neuro Sciences - Oncology - Orthopedics - Gastro Sciences - Transplants - Pediatrics - Genomics Each COE features: - Multidisciplinary care teams - Sub-specialty expertise - Rigorous performance metrics - Academic programs and clinical research - Emphasis on **advanced procedures and innovative therapies** > **New COE – Genomic Medicine (launched 2022)**: > A dedicated center offering **precision medicine, early disease prediction**, and preventive genomics, led by world-renowned geneticists and supported by DNB training and clinical trials. --- ### **Advanced Medical Technologies** IMCL remains at the forefront of adopting cutting-edge medical equipment: - **EDGE Radiotherapy System with HyperArc™** - Delivers **sub-millimeter precision** in radiosurgery - High dose rate (2400 MU/min) enables **shorter treatment times** - Advanced imaging (IGRT, CBCT) and **non-coplanar beams** for complex tumors (brain, spine, lung, liver, prostate) - Minimizes damage to healthy tissue, improves outcomes - **ZAP Gyroscopic Radiosurgery System** - **First in South Asia**, ZAP allows **non-invasive brain and head/neck cancer treatment** using optimized LINAC and self-shielding—**no radiation bunker required** - Scheduled deployment of **Zap-X** for enhanced accessibility - **Robotic Surgery Advancements** - **Da Vinci Xi Surgical System** with thinner arms, 3DHD vision, and enhanced flexibility for minimally invasive procedures - Apollo leads India in **robot-assisted surgeries**, including complex cardiac and oncology procedures - **Other Innovations**: - 3D Electrophysiology System (EPS) - SpyGlass™ for advanced gastroenterology - TCD, C-Mac video laryngoscope, and lithotripsy upgrades --- ### **Preventive & AI-Powered Care** - **Apollo ProHealth**: - An **AI-driven preventive care platform** serving **over 1 million individuals** - Uses **AI-CVD risk prediction model** and **Apollo Clinical Intelligence Engine (CIE)** to detect silent risks (e.g., heart disease, diabetes, stroke) - Offers **personalized health insights, lifestyle coaching**, and continuous monitoring - Linked to **periodic health assessments** and early intervention protocols - **AI Integration Across Care Spectrum**: AI tools now support: - Risk prediction - Early diagnosis - Personalized treatment plans - Smart inpatient room automation - Enhanced clinical decision-making > Mission: Shift from **reactive** to **proactive, predictive, and personalized healthcare**. --- ### **Telemedicine & Remote Care Infrastructure** Apollo operates **India’s most extensive telehealth network**: - **Integrated Telemedicine Services**: - Primary and specialist consults - Tele-radiology, tele-ECG, e-ICU, and ophthalmology - **Apollo Connect Program**: - Integrates **hospitals and nursing homes nationwide** to improve care coordination and clinical skilling - Supports **decentralized, localized treatment** - **Command Stations**: Located at flagship hospitals, manage **thousands of teleconsultations daily** - **Apollo Emergency Ambulance Network (1066)**: Provides **immediate doorstep care**, integrated with hospital command centers - **Home Healthcare Services**: Includes nurse/doctor visits, physiotherapy, geriatric care, pre/post-op support, and home diagnostics --- ### **Retail & Alternative Care Delivery** Reflecting evolving consumer preferences, Apollo is expanding **capital-efficient, high-return healthcare formats**: - **Neighborhood Clinics** - **Single-Specialty Centers** (fertility, maternity, ophthalmology, dental, dialysis, diabetic care) - **Daycare & Birthing Centers** - **Diagnostic Chains & Dental Clinics** - **Home Services & Short-Stay Centers** > These formats offer **lower capex, faster breakeven**, and better specialization—increasing reach and accessibility, particularly in urban and semi-urban areas. --- ### **Global Outreach & Partnerships** - **Medical Value Travel (MVT)**: IMCL is a top MVT destination, offering **world-class care at ~1/10th the cost** of Western countries. Global market valued at **$600 billion**—a key growth avenue. - **Government of Tripura Partnership**: Provides **free pediatric heart surgeries** to underserved populations - **International Collaboration**: Joint programs with **Mayapada Healthcare Group (Indonesia)** in oncology, cardiology, neurology, and transplants - **Academic Alliance**: Partnership with the **University of Leicester** to develop future clinical leaders and advance research --- ### **Brand Strength & Talent Attraction** - Recognized for **clinical excellence, safety, and patient trust** - Strong employer brand attracts **top-tier medical and managerial talent** from India and abroad - Physicians known for **high success rates in critical and complex surgeries** --- ### **Public-Private Partnerships (PPPs) & Social Impact** - Played a vital role during the pandemic via **Project Kavach**: - AI-based COVID screener - Teleconsultations, home care, hotel quarantine model - Treated **over 63,000 inpatients**, supported **16 state governments** and central agencies - Expanded preventive outreach via **mobile clinics (e.g., Samsung-Apollo Mobile Clinic)** for early NCD screening in urban areas ---